Handelsbanken Fonder AB »

Sage Therapeutics shares owned by Handelsbanken Fonder AB

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Handelsbanken Fonder AB from 13F filings

Historical chart of Handelsbanken Fonder AB investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Handelsbanken Fonder AB

Quarter filed Position value Share count Share price at filing
2023-12-31 $274k 13k 21.67
2023-09-30 $201k 9.7k 20.63
2023-06-30 $458k 9.7k 47.00
2023-03-31 $409k 9.7k 41.97
2022-12-31 $372k 9.7k 38.18
2022-09-30 $382k 9.7k 39.20
2022-06-30 $315k 9.7k 32.33
2022-03-31 $323k 9.7k 33.15
2021-12-31 $415k 9.7k 42.59
2021-09-30 $432k 9.7k 44.34
2021-06-30 $554k 9.7k 56.86
2021-03-31 $744k 9.9k 74.82
2020-12-31 $860k 9.9k 86.48
2020-09-30 $498k 8.1k 61.15
2020-06-30 $339k 8.1k 41.63
2017-06-30 $1.1M 14k 79.64
2017-03-31 $1.3M 18k 71.06